Cargando…
Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma
PURPOSE: Pheochromocytoma/paraganglioma (PCC/PGL; collectively known as PPGL) can be driven by germline and somatic mutations in susceptibility genes. We aimed to investigate the mutation profile and clinical features of pathogenic genes in highly genetically heterogeneous PPGL and to preliminary ex...
Autores principales: | Ma, Xiaosen, Ling, Chao, Zhao, Meng, Wang, Fen, Cui, Yunying, Wen, Jin, Ji, Zhigang, Zhang, Caili, Chen, Shi, Tong, Anli, Li, Yuxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368203/ https://www.ncbi.nlm.nih.gov/pubmed/35966080 http://dx.doi.org/10.3389/fendo.2022.921645 |
Ejemplares similares
-
Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study
por: Ma, Xiaosen, et al.
Publicado: (2020) -
Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
por: Tong, Anli, et al.
Publicado: (2020) -
Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes
por: Cui, Yunying, et al.
Publicado: (2021) -
A Novel Phenotype of Germline Pathogenic Variants in MAX: Concurrence of Pheochromocytoma and Ganglioneuroma in a Chinese Family and Literature Review
por: Chang, Xiaoyan, et al.
Publicado: (2020) -
Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
por: Gao, Yinjie, et al.
Publicado: (2021)